Skip to content
S5135Senate2023-2024 SessionSame asA6314

Inform Men About Prostate Testing

Official title

“Creates an educational pamphlet regarding the importance of prostate-specific antigen testing”

Sponsor Roxanne J. PersaudSD-19+1 co-sponsorAffects Health
Status
In Senate Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires the creation and distribution of an educational pamphlet on prostate-specific antigen testing and prostate cancer for adult men with a prostate in New York.

Why it matters

  1. Expands access to crucial health information. By requiring the creation of an educational pamphlet specifically about prostate cancer and PSA testing, the bill ensures that adult men with a prostate receive clear, accessible information to make informed decisions about their health, potentially increasing early detection rates.

  2. Targets health equity and language barriers. The pamphlet must be available not only in English but also in the six most common non-English languages spoken by people with limited English proficiency in New York, reducing disparities in access to cancer information among diverse communities.

  3. Clarifies provider responsibilities and patient reach. Health care providers are encouraged (but not strictly required) to distribute and discuss the pamphlet with adult men with a prostate who are at risk for, or diagnosed with, prostate cancer, ensuring that those most in need get tailored information at key points in their care.

  4. Updates and modernizes patient education. The law updates and replaces an outdated written summary requirement, mandating regular updates to the pamphlet so that patients and providers can rely on current, comprehensive, and relevant information about prostate cancer detection, treatment options, and insurance coverage.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Inform Men About Prostate Testing

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Roxanne J. Persaud

Senator · Senate District 19

Chair, Social Services

1 Co-sponsor

History

  1. Referred to health
  2. Print number 5135a
  3. Amend (t) and recommit to health
  4. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A6314Assembly

Prostate Testing Info Pamphlet

In Assembly Committee · Health · Sponsor Jeffrey Dinowitz

Impact 4 · Low0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

5135--A

2023-2024 Regular Sessions

IN SENATE

February 23, 2023

Introduced by Sen. PERSAUD -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the public health law, in relation to creating an educational pamphlet regarding the importance of prostate-specific antigen testing

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 2404-a of the public health law, as amended by chapter 335 of the laws of 2018, is amended to read as follows:

§ 2404-a. Prostate cancer; duty to inform; educational pamphlet. 1. The commissioner shall develop [a standardized written summary] an educational pamphlet, in plain non-technical language, which shall explain the following:

(a) the symptoms and risk factors for prostate cancer;

(b) the available methods for the detection and diagnosis of prostate cancer, including information on the relative accuracy of the available detection and diagnostic techniques, including, but not limited to, prostate-specific antigen testing;

(c) the availability of insurance coverage for diagnostic screening for prostate cancer without cost sharing pursuant to subparagraph (B) of paragraph eleven-a of subsection (i) of section three thousand two hundred sixteen, subparagraph (B) of paragraph eleven-a of subsection (1) of section three thousand two hundred twenty-one and paragraph two of subsection (z-1) of section four thousand three hundred three of the insurance law; and

(d) the alternative medically viable methods of treating prostate cancer, including but not limited to hormonal, radiological, chemotherapeutic or surgical treatments, or combinations thereof. The [summary] educational pamphlet shall contain information on prostate post-treat-

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD07206-04-3

ment risks and other pertinent information to aid a person in deciding a course of treatment. The [summary] educational pamphlet shall be updated as is necessary.

2. The [summary] educational pamphlet shall be provided to any health care provider or practitioner providing medical treatment to adult men with a prostate without charge or fee for distribution in accordance with subdivision three of this section.

3. The [standardized written summary] educational pamphlet provided for by subdivision one of this section may be provided by a health care provider to [each person] adult men with a prostate under his or her care [who]. Health care providers may provide to and discuss with each adult man with a prostate under his or her care the educational pamphlet where such adult man with a prostate is or may be at risk for prostate cancer or who has been diagnosed to be afflicted with prostate cancer upon said diagnosis, or as soon thereafter as practicable. The informational pamphlet shall be written in layperson's language and shall be made available in English and the six most common non-English languages spoken by individuals with limited English proficiency in New York state as based on the most recent census.

4. Nothing in this section shall be construed to create a cause of action for lack of informed consent in any instance in which such cause of action would be limited by section twenty-eight hundred five-d of this chapter.

[5. The commissioner shall have the written summary, required by this section, completed and prepared for distribution on or before January first, nineteen hundred ninety-eight.]

§ 2. This act shall take effect on the ninetieth day after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to creating an educa- tional pamphlet regarding the importance of prostate-specific antigen testing

Purpose

Creates an educational program regarding the importance of prostate-spe- cific antigen testing.

Summary of provisions

Section I Section 2404-a of the public health law, as amended by, chap- ter 335 of the laws of 2018, is amended by establishing the development of educational pamphlets relating to prostate cancer and screening.

Justification

Prostate cancer is the second leading cause of cancer in men, according to the American Cancer Society, with an estimated 288,300 new cases for 2023. A person with a prostate is at risk of developing prostate cancer, but has a higher risk of developing prostate cancer when such person has a family history. Lack of awareness and stigma contribute to patients' reduced participation in screening for prostate cancer. Furthermore, recent research by Leszczynski et. al. (2022) suggests that COVID-19 has negatively impacted the diagnosis and treatment of prostate cancer, contributing to a rise in new cases since the pandemic started. This will be particularly impactful in communities of African descent (where black men are 70% more likely to develop prostate cancer and more than twice as likely to die from it), communities of Indigenous and Hispanic descent (where American Indian, Alaska Native and Hispanic men are twice as likely to develop prostate cancer), and communities of Asian descent (where Asian American and Pacific Islanders are three times as likely to develop prostate cancer), as reported by CA A Journal for Clinicians and the National Institute for Cancer.The creation and distribution of educational materials related to pros tate-specific antigen screening can combat these factors by allowing patients to make informed decisions regarding their health, which can also save them money over the long term.

Legislative history

New bill.

Fiscal impact on the state

To be determined.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.